U
Targeted Medical Pharma, Inc. TRGM
$0.00 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

12/31/2015 09/30/2015 06/30/2015 03/31/2015 12/31/2014
Net Income 21.85% -106.14% -80.01% 54.20% 58.29%
Total Depreciation and Amortization -42.62% -32.42% -21.65% -12.42% -2.43%
Total Amortization of Deferred Charges -19.86% -22.18% -20.07% -16.39% 12.93%
Total Other Non-Cash Items -88.11% -75.57% -28.65% -93.22% -89.68%
Change in Net Operating Assets -65.20% 378.17% 1,454.11% 471.97% 1,198.34%
Cash from Operations -263.86% 16.22% 24.34% 71.83% 138.12%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -100.00% -100.00% 88.60% 100.00%
Cash from Investing -- -100.00% -100.00% 94.25% 100.00%
Total Debt Issued 1,400.00% -28.29% -19.18% -34.77% -95.72%
Total Debt Repaid 63.17% 59.94% 40.22% 3.76% -71.19%
Issuance of Common Stock -- -100.00% -100.00% -100.00% -4.00%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 207.07% -7.87% -24.29% -66.96% -154.02%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 114.75% 84.29% -375.00% 277.46% -390.73%
Weiss Ratings